Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Not so fast, according to a new study that found pre-surgery immunotherapy was effective for a common type of colorectal cancer.
Only half the time, according to an NCCN study of people with neuroendocrine tumors. Here’s how their treatment goals differ.
Imagine a world where millions of cancer deaths are prevented and access to lifesaving cancer treatment and care is equitable for all.
More than half of the therapies in positive industry-sponsored Phase III trials don’t help people with cancer live longer.
Taking the brakes off the immune system can lead to excessive responses that harm healthy organs and tissue.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.